While IL13 expression was not detected in any of the cell types we evaluated, suggesting a signal strength issue; CD36, FABP4 and TFF3, genes that are targets of IL13 signaling, were upregulated (53–55), and ATF3, which inhibits IL13 transcription (56), was downregulated in LECs from NASH livers (Figure 5A). The gene discussed is CD36; the disease is metabolic dysfunction-associated steatohepatitis.